Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

Increased hazard of mortality in cases compatible with SARS-CoV-2 variant of concern 202012/1 - a matched cohort study

View ORCID ProfileRobert Challen, View ORCID ProfileEllen Brooks-Pollock, View ORCID ProfileJonathan M Read, View ORCID ProfileLouise Dyson, View ORCID ProfileKrasimira Tsaneva-Atanasova, View ORCID ProfileLeon Danon
doi: https://doi.org/10.1101/2021.02.09.21250937
Robert Challen
1College of Engineering, Mathematics and Physical Sciences, University of Exeter, Exeter, Devon, UK.
2Somerset NHS Foundation Trust, Taunton, Somerset, UK.
3Joint Universities Pandemic and Epidemiological Research (JUNIPER) consortium.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Robert Challen
  • For correspondence: rc538@exeter.ac.uk
Ellen Brooks-Pollock
3Joint Universities Pandemic and Epidemiological Research (JUNIPER) consortium.
4University of Bristol, Bristol Veterinary School, Langford, Bristol, UK.
5Bristol Medical School, Population Health Sciences, University of Bristol, Bristol, UK.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Ellen Brooks-Pollock
Jonathan M Read
3Joint Universities Pandemic and Epidemiological Research (JUNIPER) consortium.
6Lancaster Medical School, Lancaster University, Bailrigg, Lancaster, UK.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Jonathan M Read
Louise Dyson
3Joint Universities Pandemic and Epidemiological Research (JUNIPER) consortium.
7The Zeeman Institute for Systems Biology & Infectious Disease Epidemiology Research, School of Life Sciences and Mathematics Institute, University of Warwick, Coventry, UK.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Louise Dyson
Krasimira Tsaneva-Atanasova
1College of Engineering, Mathematics and Physical Sciences, University of Exeter, Exeter, Devon, UK.
8The Alan Turing Institute, British Library, 96 Euston Rd, London, UK.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Krasimira Tsaneva-Atanasova
Leon Danon
3Joint Universities Pandemic and Epidemiological Research (JUNIPER) consortium.
5Bristol Medical School, Population Health Sciences, University of Bristol, Bristol, UK.
8The Alan Turing Institute, British Library, 96 Euston Rd, London, UK.
9Department of Engineering Mathematics, University of Bristol, UK.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Leon Danon
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Supplementary material
  • Data/Code
  • Preview PDF
Loading

Abstract

Objectives To establish whether there is any change in mortality associated with infection of a new variant of SARS-CoV-2, designated a Variant of Concern in December 2020 (VOC-202012/1) compared to that associated with infection with circulating SARS-CoV-2 variants.

Design Matched cohort study. Cases are matched by age, gender, ethnicity, index of multiple deprivation, lower tier local authority region, and sample date of positive specimen, and differing only by detectability of the spike protein gene using the TaqPath assay - a proxy measure of VOC-202012/1 infection.

Setting United Kingdom, community - based (Pillar 2) COVID-19 testing centres using the TaqPath assay.

Participants 54,906 pairs of participants testing positive for SARS-CoV-2 in Pillar 2 between 1st October 2020 and 29th January 2021, followed up until the 12th February 2021.

Main outcome measures Death within 28 days of first positive SARS-CoV-2 test.

Results There is a high probability that the risk of mortality is increased by infection with VOC-202012/01 (p <0.001). The mortality hazard ratio associated with infection with VOC-202012/1 compared to infection with previously circulating variants is 1.64 (95% CI 1.32 - 2.04) in patients who have tested positive for COVID-19 in the community. In this comparatively low risk group, this represents an increase from 2.5 to 4.1 deaths per 1000 detected cases.

Conclusions If this finding is generalisable to other populations, VOC-202012/1 infections have the potential to cause substantial additional mortality compared to previously circulating variants. Healthcare capacity planning, national and international control policies are all impacted by this finding, with increased mortality lending weight to the argument that further coordinated and stringent measures are justified to reduce deaths from SARS-CoV-2.

Competing Interest Statement

The authors have declared no competing interest.

Funding Statement

Funding: RC and KTA gratefully acknowledge the financial support of the EPSRC via grants EP/N014391/1, EP/T017856/1, and NHS England, Global Digital Exemplar programme. LDanon and KTA gratefully acknowledge the financial support of The Alan Turing Institute under the EPSRC grant EP/N510129/1. LDanon, RC and EBP are supported by MRC (MC/PC/19067). JMR acknowledges support from EPSRC (EP/N014499/1) and MRC (MR/S004793/1, MR/V028456/1). EBP was partly supported by the NIHR Health Protection Research Unit in Behavioural Science and Evaluation at University of Bristol, in partnership with Public Health England (PHE). LDanon, EBP, JMR and LDyson are further supported by MRC (MR/V038613/1) and LDanon by EPSRC EP/V051555/1. LDyson also received support through the MRC through the COVID-19 Rapid Response Rolling Call (grant number MR/V009761/1).

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

The data were supplied from the SGSS database and death reports after anonymisation under strict data protection protocols agreed between the University of Exeter and Public Health England. The ethics of the use of these data for these purposes was agreed by Public Health England with the Governments SPI-M(O) / SAGE committees. The research was assessed as not needing NHS Research Ethics Committee review.

All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

Footnotes

  • Updated data to 12th Feb 2021. Addressed peer review comments. Further analysis on time dependence of hazards.

Data Availability

The data are available on request and appropriate data sharing agreement from Public Health England. Code for the analysis is available at doi: 10.5281/zenodo.4501299

https://doi.org/10.5281/zenodo.4543510

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY 4.0 International license.
Back to top
PreviousNext
Posted February 27, 2021.
Download PDF

Supplementary Material

Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
Increased hazard of mortality in cases compatible with SARS-CoV-2 variant of concern 202012/1 - a matched cohort study
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Increased hazard of mortality in cases compatible with SARS-CoV-2 variant of concern 202012/1 - a matched cohort study
Robert Challen, Ellen Brooks-Pollock, Jonathan M Read, Louise Dyson, Krasimira Tsaneva-Atanasova, Leon Danon
medRxiv 2021.02.09.21250937; doi: https://doi.org/10.1101/2021.02.09.21250937
Digg logo Reddit logo Twitter logo Facebook logo Google logo LinkedIn logo Mendeley logo
Citation Tools
Increased hazard of mortality in cases compatible with SARS-CoV-2 variant of concern 202012/1 - a matched cohort study
Robert Challen, Ellen Brooks-Pollock, Jonathan M Read, Louise Dyson, Krasimira Tsaneva-Atanasova, Leon Danon
medRxiv 2021.02.09.21250937; doi: https://doi.org/10.1101/2021.02.09.21250937

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Infectious Diseases (except HIV/AIDS)
Subject Areas
All Articles
  • Addiction Medicine (174)
  • Allergy and Immunology (421)
  • Anesthesia (97)
  • Cardiovascular Medicine (901)
  • Dentistry and Oral Medicine (170)
  • Dermatology (102)
  • Emergency Medicine (257)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (407)
  • Epidemiology (8790)
  • Forensic Medicine (4)
  • Gastroenterology (405)
  • Genetic and Genomic Medicine (1864)
  • Geriatric Medicine (179)
  • Health Economics (388)
  • Health Informatics (1292)
  • Health Policy (644)
  • Health Systems and Quality Improvement (492)
  • Hematology (207)
  • HIV/AIDS (395)
  • Infectious Diseases (except HIV/AIDS) (10567)
  • Intensive Care and Critical Care Medicine (564)
  • Medical Education (193)
  • Medical Ethics (52)
  • Nephrology (218)
  • Neurology (1756)
  • Nursing (103)
  • Nutrition (266)
  • Obstetrics and Gynecology (343)
  • Occupational and Environmental Health (461)
  • Oncology (965)
  • Ophthalmology (283)
  • Orthopedics (107)
  • Otolaryngology (177)
  • Pain Medicine (118)
  • Palliative Medicine (43)
  • Pathology (264)
  • Pediatrics (557)
  • Pharmacology and Therapeutics (266)
  • Primary Care Research (219)
  • Psychiatry and Clinical Psychology (1845)
  • Public and Global Health (3986)
  • Radiology and Imaging (655)
  • Rehabilitation Medicine and Physical Therapy (344)
  • Respiratory Medicine (535)
  • Rheumatology (215)
  • Sexual and Reproductive Health (178)
  • Sports Medicine (166)
  • Surgery (197)
  • Toxicology (37)
  • Transplantation (106)
  • Urology (80)